← Leaderboards
Zhiqiang Lu
Armagen Technologies, Inc.
$1,163,649
Attributed
$1,163,649
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $646.2K · FY2011–13$1M$750K$500K$250K$0
'11
'12
'13
Funding mix
By agency
NIH$1,163,649 · 2
By mechanism
R44$1,052,435 · 1
R43$111,214 · 1
Top collaborators
No co-investigators on record.
Most similar at Armagen Technologies, Inc.
Same institution · by research overlap
- Yun Zhang$1,163,033
- Yufeng Zhang$1,374,008
- Ka-Wai Hui$1,268,199
Others in their field
Top investigators on “Enzyme Activity”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$47,808,754
- Susan Abushakra · Alzheon, Inc.$47,265,244
- David Heimbrook · Leidos Biomedical Research, Inc.$45,964,082
- Stuart L Schreiber · Harvard University (Medical School)$40,631,496
- Keith O Hodgson · Stanford University$37,935,767
Research focus
Enzyme ActivityExhibitsChinese Hamster Ovary CellEngineeringEnzyme Replacement TherapyEnzymesBinding (Molecular Function)Chinese HamsterDoseDrug KineticsAffinityEnzyme-Linked Immunosorbent AssayBlood - Brain Barrier AnatomyBrainBrain CellBrain DiseasesBiochemicalAffinity ChromatographyAffectCellsDrug DevelopmentChildChimeric ProteinsFuture
Grant awards (3)
Enzyme replacement therapy of the brain in Mucopolysaccharidosis Type II$646,237
R44 · FY2013 · NS · contact PI
Enzyme replacement therapy of the brain in Mucopolysaccharidosis Type II$406,198
R44 · FY2012 · NS · contact PI
Enzyme replacement therapy of the brain in Mucopolysaccharidosis Type II$111,214
R43 · FY2011 · NS · contact PI